A comparative study of alternative conduits for lower extremity revascularization: all-autogenous conduit versus prosthetic grafts
- PMID: 11107079
- DOI: 10.1067/mva.2000.111279
A comparative study of alternative conduits for lower extremity revascularization: all-autogenous conduit versus prosthetic grafts
Abstract
Purpose: In the absence of an adequate ipsilateral greater saphenous vein, various alternative conduits have been used for the performance of lower extremity revascularization. In this study we compared the effectiveness of all-autogenous arm vein bypass grafts with that of prosthetic grafts.
Methods: Seven hundred forty lower extremity revascularization procedures (506 arm vein, 234 prosthetic) performed between 1990 and 1999 were followed prospectively by means of a computerized vascular registry.
Results: Bypass graft configurations were femoro-above-knee-popliteal (26 arm vein, 100 prosthetic); femoro-below-knee-popliteal (38 arm vein, 29 prosthetic); femorotibial (174 arm vein, 55 prosthetic); femoropedal (23 arm vein, 2 prosthetic); popliteotibial/pedal (101 arm vein, 1 prosthetic); and extension "jump" grafts (144 arm vein, 47 prosthetic). The indications for surgery were limb salvage (98.0% arm vein, 89.7% prosthetic) and disabling claudication (2.0% arm vein, 10.3% prosthetic). The mean follow-up was 23.4 months (range, 1 month-7.4 years). Overall patient survival at 4 years was 54% (arm vein) and 69% (prosthetic). Cumulative patency varied with graft configuration. The 1-year primary patency rates for femorotibial grafts were 81.6% +/- 3.6% (arm vein) and 58.0% +/- 8.4% (prosthetic); the 3-year rates were 68.3% +/- 6.1% (arm vein) and 41.1% +/- 9.8% (prosthetic) (P<.01). The 1-year limb salvage rates for femorotibial grafts were 91.1% +/- 2.8% (arm vein) and 69.1% +/- 8. 8% (prosthetic); the 3-year rates were 81.4% +/- 5.6% (arm vein) and 63.2% +/- 10.3% (prosthetic) (P =.02). The 1-year primary patency rates for femoro-below-knee-popliteal grafts were 92.9% +/- 5.1% (arm vein) and 83.4% +/- 8.0% (prosthetic); the 3-year rates were 72.8% +/- 10.1% (arm vein) and 55.5% +/- 12.1% (prosthetic) (P=.05). The 1-year limb salvage rates for femoro-below-knee-popliteal grafts were 100% (arm vein) and 91.3% +/- 7.0% (prosthetic); the 3-year rates were 94.7% +/- 7.3% (arm vein) and 75.3% +/- 14.6% (prosthetic) (P = NS).
Conclusion: In this study autogenous arm vein grafts demonstrated increased patency and limb salvage, compared with prosthetic grafts. These increases achieved statistical significance in the femoro-below-knee-popliteal and femorotibial configurations. An effort to use an all-autogenous vein conduit is justified on the basis of these results; however, if no autogenous vein is available, prosthetic grafts provide a reasonable alternative to primary amputation.
Similar articles
-
Arm vein conduit is superior to composite prosthetic-autogenous grafts in lower extremity revascularization.J Vasc Surg. 2000 Jun;31(6):1119-27. doi: 10.1067/mva.2000.106488. J Vasc Surg. 2000. PMID: 10842148
-
The use of arm vein in lower-extremity revascularization: results of 520 procedures performed in eight years.J Vasc Surg. 2000 Jan;31(1 Pt 1):50-9. doi: 10.1016/s0741-5214(00)70067-x. J Vasc Surg. 2000. PMID: 10642708
-
Arm vein conduit vs prosthetic graft in infrainguinal revascularization for critical leg ischemia.J Vasc Surg. 2010 Sep;52(3):616-23. doi: 10.1016/j.jvs.2010.04.013. Epub 2010 Jul 7. J Vasc Surg. 2010. PMID: 20615645
-
Comparative decades of experience with glutaraldehyde-tanned human umbilical cord vein graft for lower limb revascularization: an analysis of 1275 cases.J Vasc Surg. 2002 Jan;35(1):64-71. J Vasc Surg. 2002. PMID: 11802134 Review.
-
Popliteal artery aneurysms. Factors associated with thromboembolism and graft failure.Int Angiol. 2004 Mar;23(1):54-65. Int Angiol. 2004. PMID: 15156131 Review.
Cited by
-
Interpenetrating network design of bioactive hydrogel coatings with enhanced damage resistance.J Mater Chem B. 2023 Jun 21;11(24):5416-5428. doi: 10.1039/d2tb02825e. J Mater Chem B. 2023. PMID: 36825927 Free PMC article.
-
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia.Eur J Vasc Endovasc Surg. 2019 Jul;58(1S):S1-S109.e33. doi: 10.1016/j.ejvs.2019.05.006. Epub 2019 Jun 8. Eur J Vasc Endovasc Surg. 2019. PMID: 31182334 Free PMC article.
-
Evaluation of endothelialization in the center part of graft using 3 cm vascular grafts implanted in the abdominal aortae of the rat.J Artif Organs. 2017 Sep;20(3):221-229. doi: 10.1007/s10047-017-0957-6. Epub 2017 May 12. J Artif Organs. 2017. PMID: 28500497
-
Long-term results of tissue-engineered small-caliber vascular grafts in a rat carotid arterial replacement model.J Artif Organs. 2012 Dec;15(4):399-405. doi: 10.1007/s10047-012-0652-6. Epub 2012 Jul 18. J Artif Organs. 2012. PMID: 22806242
-
Surface Coating of Polytetrafluoroethylene with Extracellular Matrix and Anti-CD34 Antibodies Facilitates Endothelialization and Inhibits Platelet Adhesion Under Sheer Stress.Tissue Eng Regen Med. 2017 Mar 2;14(4):359-370. doi: 10.1007/s13770-017-0044-3. eCollection 2017 Aug. Tissue Eng Regen Med. 2017. PMID: 30603492 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous